Immunocore to present at the Jefferies 2019 Global Healthcare Conference in New York

(Oxfordshire, UK and Conshohocken, Pennsylvania and Rockville, Maryland, US, 30 May 2019) Immunocore Limited, a leading T cell receptor (TCR) biotechnology company, today announces that Bahija Jallal, Chief Executive Officer, and David Berman, Head of Research and Development, will be presenting at the Jefferies 2019 Global Healthcare Conference in New York on Friday 7 June at 2:30pm ET.

 For meeting requests, please contact Julian Hirst at Julian.Hirst@immunocore.com.